Symbol | Exchange | Currency |
|---|
Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Technology, Utilities and Consumer Services sectors propelled shares higher while losses in the...
Here's a roundup of top developments in the biotech space over the last 24 hours:Stocks In FocusNovavax Receives Much Awaited FDA Nod For Protein-Based COVID-19 VaccineThe FDA...
Here's a roundup of top developments in the biotech space over the last 24 hours:Stocks In FocusNovavax Receives Much Awaited FDA Nod For Protein-Based COVID-19 VaccineThe FDA...
ContraFect Corporation is a late clinical-stage biotechnology company. The Company is focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lead DLA product candidate, exebacase (CF-301), is used for the treatment of methicillin-resistant S. aureus (MRSA) bloodstream infections (bacteremia), including right-sided endocarditis, when used in addition to standard-of-care (SOC) anti-staphylococcal antibiotics in adult patients. Its other product candidate, CF-370, is designed to target a range of gram-negative bacteria, including P. aeruginosa and has demonstrated potent in vivo activity against extensively drug-resistant (XDR) strains. It has developed an, engineered variant of exebacase, known as CF-296. It is conducting further in vitro and in vivo characterization of CF-296 to evaluate the full profile of this compound.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.964 | 0.99 | 0.952 | 0.000 | 0.00% | 0.00 | London | |||
| 150.00 | 150.80 | 147.80 | 0.00 | 0.00% | 1.38M | London | |||
| 83.00 | 84.23 | 81.78 | +0.35 | +0.42% | 35.11M | London | |||
| 146.00 | 146.00 | 146.00 | 0.00 | 0.00% | 15.64K | London | |||
| 486.60 | 499.70 | 470.00 | -4.30 | -0.88% | 181.82K | London | |||
| 3,846.00 | 3,886.00 | 3,840.50 | -37.0 | -0.95% | 1.29M | London | |||
| 47.00 | 47.98 | 45.66 | +0.20 | +0.43% | 694.77K | London | |||
| 121.44 | 122.04 | 118.10 | +2.80 | +2.36% | 47.28M | London | |||
| 411.15 | 414.40 | 399.00 | +3.15 | +0.77% | 32.85M | London | |||
Catlinderived | 708.50 | 708.50 | 708.50 | 0.00 | 0.00% | 0.00 | London | ||
| 308.50 | 315.00 | 300.50 | -2.00 | -0.64% | 596.56K | London | |||
| 188.20 | 189.70 | 182.30 | +0.10 | +0.05% | 1.36M | London | |||
| 1,055.00 | 1,103.00 | 1,044.00 | -25.0 | -2.31% | 450.79K | London | |||
| 132.60 | 138.00 | 132.40 | -3.40 | -2.50% | 1.25M | London | |||
| 98.10 | 99.30 | 96.60 | -0.65 | -0.66% | 578.07K | London |